“…Ten studies used MTX as the combined csDMARD [ 8 , [12] , [13] , [14] , [15] , [16] , [17] , [18] , [19] , [20] ], 12 used MTX combined with LEF [ [21] , [22] , [23] , [24] , [25] , [26] , [27] , [28] , [29] , [30] , [31] , [32] ], and 5 studies used MTX and SASP [ [33] , [34] , [35] , [36] , [37] ]. Only 1 study used MTX combined with HCQ as the combined csDMARDs [ 38 ], 1 used MTX and TG [ 39 ], and 1 used MTX and IGU [ 40 ]. Therefore, 2 studies used LEF as the csDMARD for combination treatment [ 41 , 42 ], 1 used TG [ 43 ], and 1 used LEF and IGU [ 44 ].…”